11.4 Status Epilepticus, Acute Stroke & Cerebral Venous Sinus Thrombosis (CVST)
Key Takeaways
- Status epilepticus (continuous seizure activity >5 minutes or recurrent seizures without return to baseline) is a life-threatening neuro-obstetric emergency requiring immediate abortive therapy with IV Lorazepam (4 mg over 2 minutes), followed by non-sedating IV antiseizure loads (Levetiracetam 60 mg/kg or Fosphenytoin 20 mg PE/kg).
- Clinicians must rapidly distinguish status epilepticus from eclampsia; while eclampsia is treated with intravenous magnesium sulfate (4–6 g loading bolus followed by 1–2 g/h) and blood pressure control, status epilepticus in an epileptic patient requires standard antiepileptic drugs (and both should be given simultaneously if the diagnosis is ambiguous).
- Acute ischemic stroke during pregnancy or the puerperium is not a contraindication to intravenous recombinant tissue plasminogen activator (rtPA / alteplase) within 4.5 hours or mechanical endovascular thrombectomy (EVT); urgent neuroimaging (non-contrast CT or MRI with DWI) with fetal shielding must never be delayed.
- Cerebral Venous Sinus Thrombosis (CVST) classically presents with severe progressive headache, papilledema, and seizures; diagnosis is confirmed via MRV or CTV, and full therapeutic anticoagulation (LMWH or UFH) is the mandatory first-line therapy even in the presence of secondary hemorrhagic venous infarction.
Status Epilepticus, Acute Stroke & Cerebral Venous Sinus Thrombosis (CVST)
Neurological emergencies in pregnancy and the puerperium present unique diagnostic and therapeutic challenges. Pregnancy induces profound neuroendocrine alterations, expanded intravascular volume, and marked hypercoagulability that significantly increase the risk of vascular and convulsive crises. Rapid diagnosis, prompt pharmacological intervention, and appropriate multidisciplinary collaboration between obstetrics, neurology, and critical care are essential to prevent permanent maternal neurological disability and fetal demise.
1. Status Epilepticus: Definition & Neuro-Obstetric Pathophysiology
Definition
Status Epilepticus (SE) is defined as continuous, unprovoked seizure activity lasting ≥ 5 minutes, or two or more distinct seizure episodes without complete recovery of consciousness between events (Neurocritical Care Society and ILAE definitions). This definition reflects the point at which normal endogenous mechanisms fail to terminate seizure activity and irreversible neuronal injury begins.
+---------------------------------------------------------------------------------------------------+
| SYSTEMIC & FETAL IMPACT OF STATUS EPILEPTICUS |
| |
| • MATERNAL SYSTEMIC COMPLICATIONS: |
| - Phase 1 (Hyperadrenergic / Compensated, 0–30 min): Severe hypertension, tachycardia, |
| hyperthermia, massive cerebral glucose consumption, and profound lactic acidosis. |
| - Phase 2 (Decompensated, >30–60 min): Systemic hypotension, cerebral hypoperfusion, |
| hypoglycemia, rhabdomyolysis, hyperkalemia, acute kidney injury, and pulmonary edema. |
| |
| • FETAL PATHOPHYSIOLOGY: |
| - Continuous violent maternal myometrial contractions and massive catecholamine release induce |
| intense uterine artery vasoconstriction, reducing uteroplacental blood flow by up to 70%. |
| - Maternal hypoxemia, hyperthermia, and lactic acidosis cross the placenta, triggering severe |
| sustained fetal bradycardia, profound asphyxia, placental abruption, or intrauterine demise. |
+---------------------------------------------------------------------------------------------------+
2. Stepwise Pharmacological Management of Status Epilepticus
+---------------------------------------------------------------------------------------------------+
| STATUS EPILEPTICUS EMERGENCY PROTOCOL |
| |
| PHASE 1: STABILIZATION & BEDSIDE EVALUATION (0 TO 5 MINUTES) |
| • Maintain airway, 100% supplemental O2, place patient in **left lateral tilt** (relieve IVC). |
| • Check **STAT Capillary Blood Glucose** (if hypoglycemic: 50 mL D50W IV + 100 mg Thiamine IV). |
| • Establish 2 large-bore IV lines; send STAT CBC, CMP, Magnesium, Lactate, AED drug levels. |
| |
| PHASE 2: EMERGENT INITIAL ABORTIVE THERAPY (5 TO 10 MINUTES) |
| • FIRST-LINE AGENT: **Intravenous Lorazepam (Ativan) 4 mg IV push over 2 minutes**. |
| - If seizures continue after 5 to 10 minutes, repeat once (total max 8 mg). |
| • ALTERNATIVE (IF NO IV ACCESS): **Intramuscular Midazolam 10 mg IM** (for weight >40 kg) OR |
| **Rectal Diazepam 10 to 20 mg PR** OR **Intranasal Midazolam 10 mg**. |
| |
| PHASE 3: URGENT SECOND-LINE ANTISEIZURE INFUSION (10 TO 20 MINUTES) |
| • Administer immediately following benzodiazepine to prevent seizure recurrence: |
| 1. **Intravenous Levetiracetam (Keppra): 60 mg/kg IV (max 4,500 mg)** infused over 10 minutes. |
| - First-line preferred agent in pregnancy: non-sedating, zero teratogenicity concerns in |
| acute rescue, and no drug-drug interactions or hepatic enzyme induction. |
| 2. **Intravenous Fosphenytoin: 20 mg PE/kg IV (max 1,500 mg PE)** at up to 150 mg PE/min. |
| - Requires continuous ECG and blood pressure monitoring (risk of hypotension/arrhythmias). |
| 3. **Intravenous Sodium Valproate: 40 mg/kg IV (max 3,000 mg)** over 10 minutes. |
| - Highly effective, but generally avoided in 1st trimester due to neural tube defects; |
| acceptable in life-threatening status when other agents fail or in the puerperium. |
| |
| PHASE 4: REFRACTORY STATUS EPILEPTICUS (>20 TO 30 MINUTES) |
| • Transfer to ICU, perform immediate **Endotracheal Intubation**, and initiate Continuous |
| Electroencephalography (cEEG) monitoring. |
| • General Anesthetic Continuous Infusions (titrate to burst suppression on cEEG): |
| - **Propofol:** 2 mg/kg IV bolus, then 2 to 10 mg/kg/hour continuous infusion. |
| - **Midazolam:** 0.2 mg/kg IV bolus, then 0.05 to 2.0 mg/kg/hour continuous infusion. |
| - **Ketamine:** 1.5 to 3.0 mg/kg IV bolus, then 1.0 to 5.0 mg/kg/hour infusion. |
+---------------------------------------------------------------------------------------------------+
3. Differential Diagnosis: Status Epilepticus vs Eclampsia
Distinguishing epileptic status epilepticus from eclamptic seizures is crucial because their definitive pharmacotherapies and delivery pathways differ fundamentally.
| Diagnostic Parameter | Primary Epileptic Seizure / Status | Eclampsia |
|---|---|---|
| Underlying Etiology | Preexisting epilepsy, AED non-compliance, structural CNS lesion | Preeclampsia-associated cerebral vasospasm, endothelial leak, loss of cerebral autoregulation |
| Gestational Age | Any gestational age or postpartum | > 20 weeks of gestation or up to 4–6 weeks postpartum |
| Blood Pressure | Normal or transient secondary elevation during convulsion | Markedly elevated (≥140/90 mmHg, often ≥160/110 mmHg) |
| Preeclampsia Markers | Absent (normal labs, no proteinuria) | Present (proteinuria, elevated transaminases, thrombocytopenia) |
| Seizure Duration | Often prolonged (>5 min) or continuous without recovery | Typically self-limited (1–2 min), generalized tonic-clonic |
| Definitive Treatment | IV Benzodiazepines + IV Levetiracetam / Fosphenytoin | IV Magnesium Sulfate (4–6 g load + 1–2 g/h) + Antihypertensives |
| Response to Magnesium | Magnesium is INEFFECTIVE for stopping epileptic SE | Highly effective in terminating and preventing recurrent eclampsia |
| Delivery Strategy | Delivery NOT required unless persistent fetal compromise | Mandatory Delivery once maternal stabilization is achieved |
The Ambiguous Presentation Rule: If a pregnant patient at ≥20 weeks gestation presents with active generalized convulsive seizures of unknown etiology or with elevated blood pressure, ADMINISTER BOTH INTRAVENOUS MAGNESIUM SULFATE (4–6 g load) AND INTRAVENOUS LORAZEPAM (4 mg) simultaneously without delay. Magnesium treats potential eclampsia, while lorazepam aborts epileptic status.
4. Acute Stroke in Pregnancy & Puerperium
Pregnancy increases the risk of stroke 3-fold, with an overall incidence of approximately 30 per 100,000 deliveries. Over 75% of pregnancy-associated strokes occur in the late third trimester or the first 6 weeks postpartum.
Acute Ischemic Stroke (AIS)
- Etiologies: Cardioembolism (PPCM, paradoxical embolism via patent foramen ovale [PFO], mechanical valve thrombosis), arterial dissection (cervical internal carotid or vertebral artery dissection), Reversible Cerebral Vasoconstriction Syndrome (RCVS), antiphospholipid syndrome (APS), or preeclampsia-associated endothelial thrombosis.
- Emergency Neuroimaging:
- STAT Non-Contrast Head CT or Brain MRI with Diffusion-Weighted Imaging (DWI).
- Fetal Radiation Safety: Fetal radiation exposure from a maternal head CT with abdominal pelvic shielding is <0.005 mGy (the threshold for fetal teratogenesis or microcephaly is >50 mGy). DIAGNOSTIC NEUROIMAGING MUST NEVER BE WITHHELD OR DELAYED DUE TO PREGNANCY.
+---------------------------------------------------------------------------------------------------+
| REVASCULARIZATION THERAPIES IN PREGNANCY AIS |
| |
| 1. INTRAVENOUS THROMBOLYSIS (IV rtPA / ALTEPLASE): |
| • Dose: **0.9 mg/kg IV (max 90 mg)**; 10% given as bolus over 1 min, remainder over 60 min. |
| • Time Window: Within **4.5 hours of symptom onset** (last known normal). |
| • Pregnancy Safety: **Pregnancy is NOT a contraindication to IV rtPA for disabling stroke** |
| (AHA/ASA Stroke Guidelines). |
| • Molecular Pharmacology: Alteplase is a large macromolecule (~59 kDa) that **DOES NOT CROSS |
| THE PLACENTA**. Maternal neurological rescue far outweighs the slight (~1%) risk of |
| placental abruption or uterine bleeding. |
| |
| 2. ENDOVASCULAR MECHANICAL THROMBECTOMY (EVT): |
| • Indicated for Large Vessel Occlusion (LVO) of the Internal Carotid Artery (ICA) or proximal |
| Middle Cerebral Artery (MCA M1) within **6 to 24 hours of onset**. |
| • Highly safe and effective in pregnancy; minimal radiation with pelvic lead shielding. |
+---------------------------------------------------------------------------------------------------+
Hemorrhagic Stroke (Intracerebral Hemorrhage & Subarachnoid Hemorrhage)
- Etiologies: Ruptured intracranial berry aneurysm (responsible for >50% of pregnancy SAH), Arteriovenous Malformations (AVMs), and severe preeclampsia/eclampsia-induced intracerebral hemorrhage.
- Clinical Triad: Sudden "thunderclap" headache, meningismus/neck stiffness, and acute altered level of consciousness.
- Management:
- Immediate blood pressure control: IV Nicardipine infusion (5–15 mg/h) or IV Labetalol to maintain systolic blood pressure strictly between 130 and 150 mmHg.
- STAT neurosurgical consultation for emergency endovascular coiling or surgical clipping of aneurysm/AVM.
- Emergent cesarean delivery is indicated if maternal herniation is imminent or for viable gestational age under simultaneous neurosurgical-obstetric intervention.
5. Cerebral Venous Sinus Thrombosis (CVST)
Cerebral Venous Sinus Thrombosis (CVST) is the thrombosis of the dural venous sinuses (superior sagittal sinus, transverse sinus, sigmoid sinus) or cortical veins. The puerperium represents the highest-risk period in a woman's lifetime, with an incidence of 10 to 12 per 100,000 deliveries (representing a 10-fold increase over the non-pregnant baseline).
+---------------------------------------------------------------------------------------------------+
| CVST CLINICAL PRESENTATION & DIAGNOSIS |
| |
| • CLINICAL PRESENTATION: |
| - **Severe, Persistent Headache (>90% of cases):** Worsens in supine position, progresses over |
| days, refractory to simple analgesics. |
| - **Signs of Intracranial Hypertension:** Papilledema, visual obscurations, diplopia (CN VI). |
| - **Focal Neurological Deficits & Seizures (40%):** Focal motor weakness, aphasia, or focal |
| seizures with secondary generalization. |
| - **Altered Mental Status / Encephalopathy:** In severe thrombosis of deep cerebral veins. |
| |
| • DIAGNOSTIC NEUROIMAGING: |
| - **Magnetic Resonance Venography (MRV) with Brain MRI (DWI/T2* GRE)** is the gold standard. |
| - **CT Venography (CTV):** Rapid alternative; demonstrates the classic **"Empty Delta Sign"** |
| (non-enhancing triangular thrombus within the contrast-filled superior sagittal sinus). |
+---------------------------------------------------------------------------------------------------+
The Mandatory Anticoagulation Protocol: The Venous Infarction Paradox
Venous sinus thrombosis causes severe upstream venous congestion, leading to brain edema and secondary hemorrhagic venous infarction in 30% to 40% of cases.
+---------------------------------------------------------------------------------------------------+
| THE CRITICAL CLINICAL RULE IN CVST MANAGEMENT |
| |
| • **FULL THERAPEUTIC ANTICOAGULATION IS MANDATORY AS FIRST-LINE THERAPY, EVEN IN THE PRESENCE |
| OF PRE-EXISTING INTRACRANIAL HEMORRHAGE / VENOUS HEMORRHAGIC INFARCTION!** |
| |
| • CLINICAL RATIONALE: |
| - Intracranial bleeding in CVST is caused by severe backward venous hypertension resulting |
| from occluded sinus outflow. |
| - Anticoagulation arrests thrombus propagation, promotes recanalization, and restores venous |
| drainage, which paradoxically **decreases venous pressure and halts further hemorrhage**. |
| - Withholding anticoagulation out of fear of bleeding leads to catastrophic clot extension, |
| massive venous infarction, herniation, and death. |
| |
| • PHARMACOLOGICAL REGIMEN: |
| - Initial Therapy: **Therapeutic Low-Molecular-Weight Heparin (Enoxaparin 1 mg/kg SC Q12H)** |
| OR **Intravenous Unfractionated Heparin (UFH)** titrated to target aPTT 60–85 seconds. |
| - Postpartum Maintenance: Continue therapeutic anticoagulation (LMWH or Warfarin, target |
| INR 2.0–3.0) for a minimum of **3 to 6 months** (or lifelong if unprovoked / severe APS). |
| - Seizure Prophylaxis: Add **Levetiracetam (Keppra 500–1,000 mg PO/IV BID)** in patients with |
| focal deficits, seizures, or supratentorial parenchymal lesions. |
+---------------------------------------------------------------------------------------------------+
A 27-year-old G1P0 with a known history of focal epilepsy at 32 weeks of gestation is brought to the labor and delivery emergency unit by EMS with continuous generalized tonic-clonic convulsions lasting 12 minutes. She has not regained consciousness. On arrival, she is actively seizing with stertorous respirations and cyanosis. Blood pressure is 134/82 mmHg, pulse is 136 bpm, and point-of-care capillary glucose is 94 mg/dL. Her abdomen is soft without contractions, and urine dipstick shows negative protein. What is the most appropriate immediate pharmacological intervention to abort the seizure activity?
A 31-year-old G2P1 at 28 weeks of gestation presents to the emergency department 1.5 hours after the sudden onset of right-sided hemiplegia and global aphasia (NIHSS score = 16). Her blood pressure is 142/88 mmHg and heart rate is 82 bpm. An emergency non-contrast head CT performed with abdominal pelvic lead shielding shows no evidence of intracranial hemorrhage or acute territorial infarction. CT angiography reveals an acute occlusion of the left proximal middle cerebral artery (MCA M1 segment). Which of the following is the most appropriate management plan?
A 26-year-old G1P1 on postpartum day 7 following an uncomplicated cesarean delivery presents to the emergency department with a 4-day history of progressively severe, throbbing holocranial headache that is worse when lying flat and associated with nausea, vomiting, and transient visual obscurations. Physical examination reveals bilateral papilledema and a subtle left upper extremity pronator drift. A brain MRI with Magnetic Resonance Venography (MRV) confirms Cerebral Venous Sinus Thrombosis (CVST) involving the superior sagittal sinus and right transverse sinus, accompanied by a small right parietal hemorrhagic venous infarction (small intracerebral hematoma with surrounding edema). What is the mandatory first-line treatment?
A 23-year-old G1P0 at 30 weeks of gestation with refractory status epilepticus has received two doses of IV lorazepam (4 mg each) and a full loading dose of IV levetiracetam (60 mg/kg). Despite these interventions, continuous electroclinical seizure activity has now persisted for 35 minutes. Vital signs show: temperature 38.8°C (101.8°F), blood pressure 92/54 mmHg, and pulse 144 bpm. What is the next immediate management step?